Tabula Rasa HealthCare’s (NASDAQ:TRHC) lock-up period is set to end on Tuesday, March 28th. Tabula Rasa HealthCare had issued 4,300,000 shares in its public offering on September 29th. The total size of the offering was $51,600,000 based on an initial share price of $12.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the expiration of the lock-up period.
TRHC has been the topic of several research analyst reports. Zacks Investment Research raised Tabula Rasa HealthCare from a “hold” rating to a “buy” rating and set a $15.00 price objective on the stock in a research note on Tuesday, December 27th. Robert W. Baird set a $17.00 price objective on Tabula Rasa HealthCare and gave the company a “buy” rating in a research note on Thursday, January 19th. Stifel Nicolaus lifted their price objective on Tabula Rasa HealthCare from $17.00 to $19.00 and gave the company a “buy” rating in a research note on Tuesday, March 14th. Finally, Piper Jaffray Companies boosted their price target on Tabula Rasa HealthCare from $18.00 to $19.00 and gave the stock an “overweight” rating in a research report on Tuesday, March 14th. One equities research analyst has rated the stock with a sell rating and four have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $17.50.
Your IP Address:
Tabula Rasa HealthCare (NASDAQ:TRHC) opened at 13.03 on Tuesday. The firm’s market capitalization is $222.46 million. The company’s 50-day moving average price is $14.60 and its 200 day moving average price is $13.61. Tabula Rasa HealthCare has a 52-week low of $10.39 and a 52-week high of $16.85.
Tabula Rasa HealthCare (NASDAQ:TRHC) last announced its earnings results on Monday, March 13th. The company reported $0.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.11 by $0.01. The firm earned $27.30 million during the quarter, compared to the consensus estimate of $25.53 million. The company’s revenue for the quarter was up 37.9% compared to the same quarter last year. Equities research analysts predict that Tabula Rasa HealthCare will post $0.42 earnings per share for the current year.
Several large investors have recently made changes to their positions in the company. Cortina Asset Management LLC raised its stake in shares of Tabula Rasa HealthCare by 16.9% in the fourth quarter. Cortina Asset Management LLC now owns 440,685 shares of the company’s stock worth $6,601,000 after buying an additional 63,627 shares during the period. State Street Corp bought a new stake in shares of Tabula Rasa HealthCare during the fourth quarter worth about $611,000. Russell Investments Group Ltd. bought a new stake in shares of Tabula Rasa HealthCare during the fourth quarter worth about $875,000. Sio Capital Management LLC bought a new stake in shares of Tabula Rasa HealthCare during the third quarter worth about $7,303,000. Finally, Laurion Capital Management LP bought a new stake in shares of Tabula Rasa HealthCare during the third quarter worth about $430,000. 23.79% of the stock is currently owned by institutional investors.
Tabula Rasa HealthCare Company Profile
Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.
Receive News & Ratings for Tabula Rasa HealthCare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare Inc and related companies with MarketBeat.com's FREE daily email newsletter.